| 注册
首页|期刊导航|中国现代医学杂志|Nrf2信号通路在肝脏缺血再灌注损伤中的保护机制及治疗前景的研究进展

Nrf2信号通路在肝脏缺血再灌注损伤中的保护机制及治疗前景的研究进展

覃根 邓银芝

中国现代医学杂志2026,Vol.36Issue(4):35-42,8.
中国现代医学杂志2026,Vol.36Issue(4):35-42,8.DOI:10.3969/j.issn.1005-8982.2026.04.006

Nrf2信号通路在肝脏缺血再灌注损伤中的保护机制及治疗前景的研究进展

Research progress on the protective mechanisms and therapeutic prospects of the Nrf2 signaling pathway in hepatic ischemia-reperfusion injury

覃根 1邓银芝2

作者信息

  • 1. 湖北民族大学 医学部,湖北 恩施 445000
  • 2. 恩施土家族苗族自治州中心医院脾胃病科,湖北 恩施 445000
  • 折叠

摘要

Abstract

Hepatic ischemia-reperfusion injury(HIRI)is a common and unavoidable complication following liver transplantation and hepatectomy.Its pathogenesis involves multiple pathophysiological processes,including oxidative stress,sterile inflammation,mitochondrial dysfunction,and apoptosis.Nuclear factor erythroid 2-related factor 2(Nrf2)is a key regulator of cellular antioxidant responses that maintains cellular redox balance by activating the expression of antioxidant factors such as heme oxygenase-1(HO-1),superoxide dismutase(SOD),and glutathione(GSH).Nrf2 also protects the liver by inhibiting the release of pro-inflammatory factors,regulating inflammatory signaling pathways,reducing inflammatory responses,and decreasing apoptosis.This review summarizes the mechanistic roles of Nrf2 in HIRI,recent advances in Nrf2 activators,and their prospects for clinical translation.Furthermore,it discusses the application potential of cutting-edge technologies such as artificial intelligence and organoid models in Nrf2-related research,aiming to provide a theoretical basis for the prevention and treatment of HIRI through targeting the Nrf2 signaling pathway.

关键词

肝脏缺血再灌注损伤/Nrf2/抗氧化应激/抗炎/抗凋亡/Nrf2激活剂

Key words

hepatic ischemia-reperfusion injury/Nrf2/antioxidant/anti-inflammatory/anti-apoptotic/Nrf2 activators

分类

医药卫生

引用本文复制引用

覃根,邓银芝..Nrf2信号通路在肝脏缺血再灌注损伤中的保护机制及治疗前景的研究进展[J].中国现代医学杂志,2026,36(4):35-42,8.

基金项目

湖北省自然科学基金面上项目(No:2024AFB1027) (No:2024AFB1027)

中国现代医学杂志

1005-8982

访问量0
|
下载量0
段落导航相关论文